Financial insights of BSX

MyFinsight

For the quarter ending 2025-09-30, BSX made $5,065M in revenue. $755M in net income. Net profit margin of 14.91%.

Unit: Million (M) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Net sales	5,065	5,061	4,663	4,209
Cost of products sold (excluding amortization expense)	1,523	1,637	1,453	1,312
Gross profit	3,542	3,424	3,210	2,897
Selling, general and administrative expenses	1,741	1,716	1,597	1,562
Research and development expenses	514	526	443	407
Royalty expense	12	14	14	5
Amortization expense	225	225	219	205
Intangible asset impairment charges	0	46	-	0
Contingent consideration net expense (benefit)	11	-5	5	-23
Restructuring net charges (credits)	-8	83	10	8
Litigation-related net charges (credits)	-	-	-	0
Operating expenses	2,494	2,605	2,288	2,164
Operating income (loss)	1,048	819	921	733
Interest expense	87	90	82	79
Other, net	-23	213	-34	14
Income (loss)before income taxes	939	941	805	669
Income tax expense (benefit)	183	146	133	200
Net income (loss)	755	795	672	468
Preferred stock dividends	-	-	-	0
Net income (loss) attributable to noncontrolling interests	0	-2	-2	0
Net income (loss) attributable to boston scientific common stockholders	755	797	674	469

Basic	1,481,700,000	1,479,900,000	1,477,200,000	1,472,700,000
Diluted	1,495,500,000	1,493,500,000	1,493,100,000	1,487,400,000
Net income (loss)per common share basic	0.51	0.54	0.46	0.32
Net income (loss)per common share diluted	0.51	0.53	0.45	0.32